- Original Article
-
Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
-
EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee
-
Clin Mol Hepatol. 2014;20(3):267-273. Published online September 25, 2014
-
-
-
No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients
-
Nae-Yun Heo, Young-Suk Lim, Woochang Lee, Minkyung Oh, Jiyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh
-
Clin Mol Hepatol. 2014;20(2):177-184. Published online June 30, 2014
-
-
-
Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
-
Soon Ha Kwon, Soung Won Jeong, Jae Young Jang, Ji Eun Lee, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, So-Young Jin
-
Clin Mol Hepatol. 2012;18(3):287-294. Published online September 25, 2012
-
-
-
A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
-
Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
-
Clin Mol Hepatol. 2012;18(3):272-278. Published online September 25, 2012
-
-
- Original Article
-
Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients
-
Young Kul Jung, Jong Eun Yeon, Kwang Gyun Lee, Eun Seok Jung, Jeong Han Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Sun Ho Um, Ho Sang Ryu, Kwan Soo Byun
-
Clin Mol Hepatol. 2011;17(4):261-267. Published online December 26, 2011
-
-
-
Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin
-
Sang Bun Choi, Youn Jae Lee, Jae Ik Lee, Young Jin Song, Byoung Jin Choi, Jong Han Kim, Eun Uk Jung, Sung Jae Park, Sang Heon Lee, Ji Hyun Kim, Jung Sik Choi, Sam Ryong Jee, Sang Yong Seol
-
Clin Mol Hepatol. 2011;17(3):183-188. Published online September 30, 2011
-
-
- Original Article
-
Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea
-
Sang Ho Lee, Hyoung Su Kim, Kwon Oh Park, Jong Won Park, Seung Yeon Chun, Seung Jin Lim, Hyun Jung Cho, Sung Jun Kim, Hye Won Park, Han Kook Moon, Woon Geon Shin, Kyung Ho Kim, Myoung Kuk Jang, Jin Heon Lee, Hak Yang Kim
-
Clin Mol Hepatol. 2010;16(4):362-368. Published online December 31, 2010
-
-
- 3
-
Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection
-
Hong Ryeol Cheong, M.D., Hyun Young Woo, M.D., Jeong Heo, M.D.,
Ki Tae Yoon, M.D., Dong Uk Kim, M.D., Gwang Ha Kim, M.D.,
Dae Hwan Kang, M.D., Geun Am Song, M.D., Mong Cho, M.D.
-
Clin Mol Hepatol. 2010;16(1):38-48. Published online March 26, 2010
-
-
- 3
-
Efficacy of 48-week clevudine therapy for chronic hepatitis B
-
Min Hwan Kim, M.D., Kyung-Ah Kim, M.D., June Sung Lee, M.D.,
Hyun Woong Lee, M.D. Hyung Joon Kim, M.D. Sang Gu Yun, M.D.,
Nam-Hoon Kim, M.D., Won Ki Bae, M.D., Young Soo Moon, M.D.
-
Clin Mol Hepatol. 2009;15(3):331-337. Published online September 30, 2009
-
-
-
Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea
-
Byung Kook Kim, M.D., So Young Kwon, M.D., Chang Hong Lee, M.D.,
Won Hyeok Choe, M.D., Hong Mi Choi, M.S. Hye Won Koo, M.D.
-
Clin Mol Hepatol. 2009;15(1):25-41. Published online March 31, 2009
-
-
|
Impact Factor8.9
